Table 2. Multivariable analysis of factors associated with nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia (PCP) – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.
Characteristics | Adjusted Odds Ratio (95% Confidence Interval)* |
N = 1,666 | |
Illicit drug use in last year | |
No | Reference |
Marijuana only | 1.6 (1.1–2.4) |
Non-injection drugs other than marijuana | 1.5 (1.0–2.1)† |
Injection drug use | 2.3 (1.3–4.1) |
Number of days mental health described as not good last month | |
0 | Reference |
≥1 | 1.6 (1.2–2.2) |
Recent CD4 count (cells/μL) | |
<200 | 1.6 (1.1–2.2) |
≥200 | Reference |
Unknown/missing | 0.9 (0.6–1.4) |
Antiretroviral therapy (ART) in the past month | |
On ART, always adherent | Reference |
On ART, usually adherent | 9.6 (6.7–13.7) |
On ART, sometimes, rarely, or never adherent | 18.4 (11.1–30.4) |
On ART, unknown or missing information about adherence | 2.7 (1.5–4.7) |
Not taking ART | 5.1 (3.3–8.1) |
In addition to adjusting for variables included in this table, we controlled for region of residence in the U.S. and year of SHAS interview.
P-value<0.05.